130 related items for PubMed ID: 31112272
1. Height Velocity Defined Metabolic Control in Children With Congenital Adrenal Hyperplasia Using Urinary Steroid GC-MS Analysis.
Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA.
J Clin Endocrinol Metab; 2019 Sep 01; 104(9):4214-4224. PubMed ID: 31112272
[Abstract] [Full Text] [Related]
2. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia.
Kamrath C, Hartmann MF, Pons-Kühnemann J, Wudy SA.
Metabolism; 2020 Nov 01; 112():154354. PubMed ID: 32916150
[Abstract] [Full Text] [Related]
3. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2017 Jan 01; 165(Pt B):396-406. PubMed ID: 27544322
[Abstract] [Full Text] [Related]
4. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2018 Apr 01; 178():221-228. PubMed ID: 29277706
[Abstract] [Full Text] [Related]
5. Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
Kamrath C, Friedrich C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2023 Jul 01; 231():106304. PubMed ID: 36990162
[Abstract] [Full Text] [Related]
6. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM, Mallappa A, Reisch N, Nikolaou N, Krone N, Hughes BA, O'Neil DM, Whitaker MJ, Tomlinson JW, Storbeck KH, Merke DP, Ross RJ, Arlt W.
J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1797-1806. PubMed ID: 27845856
[Abstract] [Full Text] [Related]
7. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
8. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 19; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
9. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
Pussard E, Travers S, Bouvattier C, Xue QY, Cosson C, Viengchareun S, Martinerie L, Lombès M.
J Steroid Biochem Mol Biol; 2020 Apr 19; 198():105553. PubMed ID: 31778802
[Abstract] [Full Text] [Related]
10. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study.
Auchus RJ, Courtillot C, Dobs A, El-Maouche D, Falhammar H, Lacroix A, Farrar M, O'Donoghue C, Anatchkova M, Cutts K, Taylor N, Yonan C, Lamotte M, Touraine P.
Front Endocrinol (Lausanne); 2022 Apr 19; 13():1005963. PubMed ID: 36465641
[Abstract] [Full Text] [Related]
11. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
Clin Endocrinol (Oxf); 2019 Jul 19; 91(1):124-130. PubMed ID: 31070802
[Abstract] [Full Text] [Related]
12. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
Schernthaner-Reiter MH, Baumgartner-Parzer S, Egarter HC, Krebs M, Kautzky-Willer A, Kirchheiner K, Luger A, Bayerle-Eder M.
J Sex Med; 2019 Oct 19; 16(10):1529-1540. PubMed ID: 31447379
[Abstract] [Full Text] [Related]
13. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2002 May 19; 87(5):2238-44. PubMed ID: 11994370
[Abstract] [Full Text] [Related]
14. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
Liu SC, Suresh M, Jaber M, Mercado Munoz Y, Sarafoglou K.
Front Endocrinol (Lausanne); 2023 May 19; 14():1101843. PubMed ID: 36936152
[Abstract] [Full Text] [Related]
15. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Auer MK, Krumbholz A, Bidlingmaier M, Thieme D, Reisch N.
Neuroendocrinology; 2020 May 19; 110(11-12):938-949. PubMed ID: 31711056
[Abstract] [Full Text] [Related]
16. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?
Logan LA, Nebesio TD, Eckert GJ, Eugster EA.
Horm Res Paediatr; 2022 May 19; 95(5):461-464. PubMed ID: 35649383
[Abstract] [Full Text] [Related]
17. Quantitative targeted GC-MS-based urinary steroid metabolome analysis for treatment monitoring of adolescents and young adults with autoimmune primary adrenal insufficiency.
Kamrath C, Hartmann MF, Wudy SA.
Steroids; 2019 Oct 19; 150():108426. PubMed ID: 31228484
[Abstract] [Full Text] [Related]
18. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
Ünal S, Alikaşifoğlu A, Özön A, Gönç N, Kandemir N.
Turk J Pediatr; 2020 Oct 19; 62(3):359-366. PubMed ID: 32558409
[Abstract] [Full Text] [Related]
19. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
20. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
Indian J Pediatr; 2019 Feb 25; 86(2):154-158. PubMed ID: 30097840
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
